In this Issue
Clinical Science (30 April 2018) 132 (8): 839–850.
Karen Horsburgh; Joanna M. Wardlaw; Tom van Agtmael; Stuart M. Allan; Mike L.J. Ashford; Philip M. Bath; Rosalind Brown; Jason Berwick; M. Zameel Cader; Roxana O. Carare; John B. Davis; Jessica Duncombe; Tracy D. Farr; Jill H. Fowler; Jozien Goense; Alessandra Granata; Catherine N. Hall; Atticus H. Hainsworth; Adam Harvey; Cheryl A. Hawkes; Anne Joutel; Rajesh N. Kalaria; Patrick G. Kehoe; Catherine B. Lawrence; Andy Lockhart; Seth Love; Malcolm R. Macleod; I. Mhairi Macrae; Hugh S. Markus; Chris McCabe; Barry W. McColl; Paul J. Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J. Quinn; Rikesh Rajani; Lisa M. Saksida; Colin Smith; Kenneth J. Smith; Rhian M. Touyz; Rebecca C. Trueman; Tao Wang; Anna Williams; Steven C.R. Williams; Lorraine M. Work
Clinical Science (30 April 2018) 132 (8): 851–868.
Clinical Science (30 April 2018) 132 (8): 901–904.
Clinical Science (30 April 2018) 132 (8): 869–881.
Cover ImageA representation of the intestinal microflora. In Clinical Science volume 132 (issue 7), Rajani and Jia review recent research on the effect of bacterial metabolites on host metabolism (microbiota-host co-metabolism) associated with conditions such as obesity, cardiovascular disease, diabetes and non-alcoholic fatty liver disease (pages 791-811). Then, in issue 8, Lezutekong et al. (pages 901-904) provide a commentary on a recent research by Kim et al. in Clinical Science that demonstrates a crucial link between gut microbiota and bacterial metabolites such as butyrate, gut leakiness, and hypertension. These and other articles from the journal are featured in a themed collection on the topic of the microbiome and chronic disease.